FFCP PHASE1:Hg19::chr11:46497904..46497915,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr11:46497904..46497915,- | |||
|coexpression_cluster_id=C21 | |||
|description=CAGE_peak_at_chr11:46497904..46497915,- | |||
|id=chr11:46497904..46497915,- | |||
|ontology_enrichment_celltype=CL:0000080!5.37e-34!6;CL:0000946!2.62e-23!1;CL:0000786!2.62e-23!1;CL:0000980!2.62e-23!1;CL:0000785!2.32e-12!2;CL:0000955!2.32e-12!2;CL:0000818!2.32e-12!2;CL:0000954!2.32e-12!2;CL:0000816!2.32e-12!2;CL:0000838!9.74e-11!52;CL:0000542!1.54e-10!53;CL:0000051!1.54e-10!53;CL:0000945!7.12e-09!24;CL:0000826!7.12e-09!24;CL:0000817!1.12e-08!3;CL:0000988!1.72e-07!182 | |||
|ontology_enrichment_celltype_v019= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:0060060!2.10e-23!1;DOID:0060061!2.10e-23!1;DOID:8691!2.10e-23!1;DOID:0060058!8.46e-10!10 | |||
|ontology_enrichment_disease_v019=DOID:0060060;6.58e-50;1!DOID:0060061;6.58e-50;1!DOID:8691;6.58e-50;1 | |||
|ontology_enrichment_disease_v019_2=DOID:0060060,6.58e-50,1;DOID:0060061,6.58e-50,1;DOID:8691,6.58e-50,1 | |||
|ontology_enrichment_uberon=UBERON:0002331!9.82e-21!10;UBERON:0000358!9.82e-21!10;UBERON:0000307!9.82e-21!10;UBERON:0000091!9.82e-21!10;UBERON:0000087!9.82e-21!10;UBERON:0007806!9.82e-21!10;UBERON:0008780!9.82e-21!10;UBERON:0005728!9.82e-21!10;UBERON:0000178!4.52e-14!15;UBERON:0000179!4.52e-14!15;UBERON:0000463!4.52e-14!15;UBERON:0000478!4.86e-09!24 | |||
|ontology_enrichment_uberon_v019=UBERON:0002331;4.18e-45;10!UBERON:0000178;1.81e-30;15!UBERON:0000179;1.81e-30;15!UBERON:0000463;1.81e-30;15!UBERON:0000478;1.88e-19;24!UBERON:0002390;5.88e-15;32!UBERON:0000922;9.48e-10;49!UBERON:0002193;7.34e-07;42 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002331,4.18e-45,10;UBERON:0000358,4.18e-45,10;UBERON:0000307,4.18e-45,10;UBERON:0000091,4.18e-45,10;UBERON:0000087,4.18e-45,10;UBERON:0007010,4.18e-45,10;UBERON:0007806,4.18e-45,10;UBERON:0008780,4.18e-45,10;UBERON:0005728,4.18e-45,10;UBERON:0000178,1.81e-30,15;UBERON:0000179,1.81e-30,15;UBERON:0000463,1.81e-30,15;UBERON:0000478,1.88e-19,24 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.152826811495903,0.164201178899891,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122988438543114,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.329607748453519,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.15129580152871,9.63798723782722,7.93606816241461,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.19979833367888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.345701962667338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:46497904..46497915,- | |||
}} |
Latest revision as of 22:29, 23 July 2015
Short description: | p@chr11:46497904..46497915, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr11:46497904..46497915, - |
Coexpression cluster: | C21_cord_mycosis_hairy_xeroderma_adult_CD4_anaplastic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
umbilical cord | 4.18e-45 | 10 |
blastocyst | 4.18e-45 | 10 |
blastula | 4.18e-45 | 10 |
bilaminar disc | 4.18e-45 | 10 |
inner cell mass | 4.18e-45 | 10 |
cleaving embryo | 4.18e-45 | 10 |
connecting stalk | 4.18e-45 | 10 |
inner cell mass derived epiblast | 4.18e-45 | 10 |
extraembryonic mesoderm | 4.18e-45 | 10 |
blood | 1.81e-30 | 15 |
haemolymphatic fluid | 1.81e-30 | 15 |
organism substance | 1.81e-30 | 15 |
extraembryonic structure | 1.88e-19 | 24 |
Ontology term | p-value | n |
---|---|---|
non-Hodgkin lymphoma | 6.58e-50 | 1 |
cutaneous T cell lymphoma | 6.58e-50 | 1 |
mycosis fungoides | 6.58e-50 | 1 |